Amedisys (AMED) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amedisys Reports Fourth Quarter and Year End 2020 Financial Results
February 24, 2021 4:05 PM ESTBATON ROUGE, La., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2020.
Three-Month Periods Ended December 31, 2020 and 2019
Net service revenue increased $50.0Â million to $550.7Â million compared to $500.7Â million in 2019.Net income attributable to Amedisys, Inc. of $45.2Â million compared to $27.7Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $1.36 compared to $0.83 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $78.1Â million compared to $52.2Â million in 2019.Adjusted net service revenue of $550.7Â million compared to $500.7Â million in... More